Cargando…

Zika vaccines and therapeutics: landscape analysis and challenges ahead

BACKGROUND: Various Zika virus (ZIKV) vaccine candidates are currently in development. Nevertheless, unique challenges in clinical development and regulatory pathways may hinder the licensure of high-quality, safe, and effective ZIKV vaccines. DISCUSSION: Implementing phase 3 efficacy trials will be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilder-Smith, Annelies, Vannice, Kirsten, Durbin, Anna, Hombach, Joachim, Thomas, Stephen J., Thevarjan, Irani, Simmons, Cameron P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989336/ https://www.ncbi.nlm.nih.gov/pubmed/29871628 http://dx.doi.org/10.1186/s12916-018-1067-x

Ejemplares similares

Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates
por: Vannice, Kirsten S., et al.
Publicado: (2019)

Estimating the proportion of vaccine-induced hospitalized dengue cases among Dengvaxia vaccinees in the Philippines
por: Flasche, Stefan, et al.
Publicado: (2019)

Modelling an optimum vaccination strategy against ZIKA virus for outbreak use
por: Massad, Eduardo, et al.
Publicado: (2019)

Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection
por: Staples, J. Erin, et al.
Publicado: (2020)

Asymptomatic Prenatal Zika Virus Infection and Congenital Zika Syndrome
por: Paixao, Enny S, et al.
Publicado: (2018)

Zika: How safe is India?
por: Doss, C. George Priya, et al.
Publicado: (2017)

The Scientific Response to Zika Virus
por: Martín-Acebes, Miguel A., et al.
Publicado: (2019)

Dengue vaccine development by the year 2020: challenges and prospects
por: Wilder-Smith, Annelies
Publicado: (2020)

Developing a vaccine against Zika
por: Hombach, Joachim, et al.
Publicado: (2016)

Dengue: Challenges for Policy Makers and Vaccine Developers
por: Wilder-Smith, Annelies, et al.
Publicado: (2014)

The Road Traveled and Journey Ahead for the Genetics and Genomics of Tinnitus
por: Vona, Barbara
Publicado: (2022)

TB Vaccines: The (Human) Challenge Ahead
por: Hokey, David A
Publicado: (2014)

Ecological and Evolutionary Challenges for Wildlife Vaccination
por: Barnett, K.M., et al.
Publicado: (2020)

Evidence-based decision-making for diagnostic and therapeutic methods: the changing landscape of assessment approaches in Germany
por: Olberg, Britta, et al.
Publicado: (2017)

Zika genomics urgently need standardized and curated reference sequences
por: Theys, Kristof, et al.
Publicado: (2017)

The public health value of vaccines beyond efficacy: methods, measures and outcomes
por: Wilder-Smith, A., et al.
Publicado: (2017)

Open challenges in developing digital therapeutics in the United States
por: Miao, Brenda Y., et al.
Publicado: (2022)

The Beginning of the Era of Digital Therapeutics in Korea: Challenges and Opportunities
por: Cho, Chul-Hyun
Publicado: (2023)

COVID-19 Vaccination and the Challenge of Infodemic and Disinformation
por: Farooq, Fareeha, et al.
Publicado: (2021)

Navigating the Zika panic
por: Grubaugh, Nathan D., et al.
Publicado: (2016)

Complement Factors in COVID-19 Therapeutics and Vaccines
por: Kurtovic, Liriye, et al.
Publicado: (2021)

Estimated Zika virus importations to Europe by travellers from Brazil
por: Massad, Eduardo, et al.
Publicado: (2016)

Threats of Zika virus transmission for Asia and its Hindu-Kush Himalayan region
por: Dhimal, Meghnath, et al.
Publicado: (2018)

Challenges ahead
por: Muglia, Valdair F
Publicado: (2023)

Research and development of Zika virus vaccines
por: Dawes, Brian E, et al.
Publicado: (2016)

Changing computational research. The challenges ahead
por: Neylon, Cameron, et al.
Publicado: (2012)

The global spread of Zika virus: is public and media concern justified in regions currently unaffected?
por: Gyawali, Narayan, et al.
Publicado: (2016)

Causal or not: applying the Bradford Hill aspects of evidence to the association between Zika virus and microcephaly
por: Frank, Christina, et al.
Publicado: (2016)

Hepatitis B Therapeutic Vaccine: A Patent Review
por: Hudu, Shuaibu Abdullahi, et al.
Publicado: (2022)

Zika is not a reason for missing the Olympic Games in Rio de Janeiro: response to the open letter of Dr Attaran and colleagues to Dr Margaret Chan, Director - General, WHO, on the Zika threat to the Olympic and Paralympic Games
por: Codeço, Claudia, et al.
Publicado: (2016)

Demystifying Clinical Appropriateness in Virtual Care and What Is Ahead for Pay Parity: Proceedings of the 3rd Annual Mass General Brigham Virtual Care Symposium
por: Schwamm, Lee H.
Publicado: (2023)

Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease
por: Barabas, Arpad Z, et al.
Publicado: (2007)

Open drug discovery for the Zika virus
por: Ekins, Sean, et al.
Publicado: (2016)

Rotavirus Vaccines: a story of success with challenges ahead
por: O’Ryan, Miguel
Publicado: (2017)

The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control
por: Vannice, Kirsten S., et al.
Publicado: (2021)

Zika mosquito vectors: the jury is still out
por: Leal, Walter S.
Publicado: (2016)

Rotavirus: The Challenges Ahead
por: Sengupta, Paramita
Publicado: (2009)

Mentorship-challenges ahead
por: Jain, Sanjay N
Publicado: (2014)

Development of an improved vaccine for contagious bovine pleuropneumonia: an African perspective on challenges and proposed actions
por: Jores, Joerg, et al.
Publicado: (2013)

Cancer nanomedicine: a review of nano-therapeutics and challenges ahead
por: Nirmala, M. Joyce, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iqj9dm2nasbfdu05ho9p2umicb